EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fluorodeoxyglucose PET/Computed Tomography in Multimodality and Theranostic Workflows

Yogita Khandelwal, Komal Bishnoi, Bela Jain, Rakesh Kumar

PET Clinics · 2027-01 · 22 (1) · 173-191

DOI: 10.1016/j.cpet.2026.06.015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PET Clinics, 2027-01. Verfasst von Yogita Khandelwal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India. Electronic address: ykyogita28@gmail.com. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Radiopharmaceuticals, Neoplasms. Die Arbeit nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Theranostics, the integration of diagnostic imaging and targeted radionuclide therapy, has transformed oncological practice. While receptor-targeted tracers such as somatostatin receptor PET/computed tomography (CT) and prostate-specific membrane antigen PET/CT anchor most theranostic workflows, 18F-fluorodeoxyglucose (FDG) PET/CT retains an indispensable role across the spectrum of theranostic diseases. FDG PET images glucose metabolism and thereby captures biological information that receptor-targeted tracers cannot. This review synthesizes current evidence, guideline recommendations, and emerging applications, including total-body PET, AI-assisted quantification, radiomics, and novel fibroblast activation protein inhibitor targeted theranostics, to define the evolving position of FDG-PET/CT as a gatekeeper in the theranostic oncological workflow.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18RadiopharmaceuticalsNeoplasmsHumansMultimodal ImagingWorkflow

Stichwörter der Autor:innen

177LutetiumFDG-PET/CTMultimodality imagingNeuroendocrine tumorsPERCISTPSMA PETRadioligand therapySomatostatin receptor PETTheranostics

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India. Electronic address: ykyogita28@gmail.com.
  • Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India.

Zitieren

APA

Khandelwal, Y., Bishnoi, K., Jain, B., & Kumar, R. (2027). Fluorodeoxyglucose PET/Computed Tomography in Multimodality and Theranostic Workflows. PET Clinics, 22(1), 173-191. https://doi.org/10.1016/j.cpet.2026.06.015

Vancouver

Khandelwal Y, Bishnoi K, Jain B, Kumar R. Fluorodeoxyglucose PET/Computed Tomography in Multimodality and Theranostic Workflows. PET Clinics. 2027;22(1):173-191. doi:10.1016/j.cpet.2026.06.015

BibTeX
@article{Khandelwal2027,
  author = {Khandelwal, Yogita and Bishnoi, Komal and Jain, Bela and Kumar, Rakesh},
  title = {Fluorodeoxyglucose PET/Computed Tomography in Multimodality and Theranostic Workflows},
  journal = {PET Clinics},
  year = {2027},
  volume = {22},
  number = {1},
  pages = {173--191},
  doi = {10.1016/j.cpet.2026.06.015}
}
Kostenlos starten →